Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Although antimicrobial therapy of leptospirosis has been studied in a few randomized controlled clinical studies, those studies were limited to specific regions of the world and few have characterized infecting strains. A broth microdilution technique for the assessment of antibiotic susceptibility has been developed at Brooke Army Medical Center. In the present study, we assessed the susceptibilities of 13 Leptospira isolates (including recent clinical isolates) from Egypt, Thailand, Nicaragua, and Hawaii to 13 antimicrobial agents. Ampicillin, cefepime, azithromycin, and clarithromycin were found to have MICs below the lower limit of detection (0.016 microg/ml). Cefotaxime, ceftriaxone, imipenem-cilastatin, penicillin G, moxifloxacin, ciprofloxacin, and levofloxacin had MIC(90)s between 0.030 and 0.125 microg/ml. Doxycycline and tetracycline had the highest MIC(90)s: 2 and 4 microg/ml, respectively. Doxycycline and tetracycline were noted to have slightly higher MICs against isolates from Egypt than against strains from Thailand or Hawaii; otherwise, the susceptibility patterns were similar. There appears to be possible variability in susceptibility to some antimicrobial agents among strains, suggesting that more extensive testing to look for geographic variability should be pursued.
Ressner
Roseanne A
RA
Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
Griffith
Matthew E
ME
Beckius
Miriam L
ML
Pimentel
Guillermo
G
Miller
R Scott
RS
Mende
Katrin
K
Fraser
Susan L
SL
Galloway
Renee L
RL
Hospenthal
Duane R
DR
Murray
Clinton K
CK
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017963:Azithromycin / Q000494:pharmacology; D000077723:Cefepime; D002439:Cefotaxime / Q000494:pharmacology; D002443:Ceftriaxone / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology; D004534:Egypt; D006254:Hawaii; D006801:Humans; D007919:Leptospira / Q000187:drug effects* / Q000302:isolation & purification; D007922:Leptospirosis / Q000382:microbiology; D064704:Levofloxacin; D008826:Microbial Sensitivity Tests / Q000379:methods*; D009527:Nicaragua; D015242:Ofloxacin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D013785:Thailand
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002939:Ciprofloxacin; D064704:Levofloxacin; D002443:Ceftriaxone; D000667:Ampicillin; D000077723:Cefepime; D017963:Azithromycin; D015242:Ofloxacin; D013752:Tetracycline; D002439:Cefotaxime